
Champions of Cell and Gene Therapy – The Medicine Maker
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs
The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment.
Cambridge Consultants, a world-leading product development and technology consultancy, part of Capgemini Invent, has today launched an exciting new brand platform for its clients, staff, and wider stakeholder communities, with a vibrant reimagining of its visual identity.
Greater process control, lower setup costs and simple equipment programming make it easier than ever for manufacturers to build their automation in-house rather than hire a machine builder.
A holistic approach is essential to making sure that the security of machines involved in a large-scale autonomous project can be trusted.
By Lai Chiu Tang’s top six insights into successful medical device design. Designing a medical device is a challenging creative task. Not only must it be safe, reliable, easy to use and have market appeal, the device must be accepted into people’s lives and lifestyles.